Hepatitis B

Survival for Patients With Liver Cancer Differs by Race

By

A study of nearly 1000 patients with HCC found that black patients with the disease had a 33% greater risk of death compared with non-Hispanic whites.

Chronic HBV Treatment Linked to Increased Rates of Colorectal and Cervical Cancer

Chronic HBV Treatment Linked to Increased Rates of Colorectal and Cervical Cancer

By

A potential link between long-term oral treatment with nucleos(t)ide analogues for chronic hepatitis B virus (HBV) and an increased risk of colorectal and cervical cancers was demonstrated.

Tenofovir may reduce risk of liver cancer in patients with HBV infection

Tenofovir may reduce risk of liver cancer in patients with HBV infection

Long-term therapy with tenofovir was associated with a decreased incidence of HCC among patients with chronic HBV infection without cirrhosis.

Immunosuppressives and anticancer drugs may reactivate Hepatitis B virus (HBV)

Immunosuppressives and anticancer drugs may reactivate Hepatitis B virus (HBV)

Chemotherapy or immunosuppressive treatment may reactive hepatitis B virus in patients previously infected with the virus.

Antiviral therapy may prevent liver cancer in patients with hepatitis B

Antiviral therapy may prevent liver cancer in patients with hepatitis B

Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs